Corzyna Will Be a New Med for Chronic Chest Pain

Corzyna (ranolazine) will be a new option for patients with chronic chest pain, or angina.

It's already been used in the U.S. for over a decade under the brand name Ranexa.

Corzyna will be the first angina med that doesn't affect heart rate or blood pressure.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote